Placeholder Banner

BIO Comments on SEC Proposal to Amend the Accelerated Filer and Large Accelerated Filer Definitions

November 11, 2019

In a recent letter, BIO applauded the Securities and Exchange Commission (SEC) for taking a proactive approach in amending its accelerated and large accelerated filer definitions.

“If adopted as proposed, these amendments will benefit startups and their investors by freeing up more capital to invest in hiring scientists and pursuing research and development. Our members strive to protect investors by keeping them informed, but the overwhelming success of the JOBS Act shows that there is little investor sentiment for a costly one-size-fits-all compliance requirement, and they are instead more concerned with our ability to attract talent and innovate.”

Download Full Comments Below
BIO Comments on SEC Accelerated Filer Proposed Rule
Discover More
The Biotechnology Innovation Organization provided comments to the Treasury Department and Internal Revenue Service on proposed regulations under Section 382 with respect to the built-in gain and built-in loss rules of Section 382(h).
In a recent letter, BIO’s Jim Greenwood commended Representative Steil (R-WI) for introducing the “Helping Startups Continue to Grow Act,” which extends the exemption afforded to Emerging Growth Companies under the JOBS Act from certain executive…
The Biotechnology Innovation Organization (BIO) responded to the SEC’s request for comments on the nature and timing of disclosures that reporting companies are required to provide in their quarterly reports. BIO believes that the current quarterly…